Home | Research Accomplishments | Services & Requests | Equipment and Software | Authorship Policy
The BSR serves all Rutgers Cancer Institute research programs. From 2018 to 2022, BSR statisticians have authored 140 publications. The top 25 research publications include publications include:
- Thirteen publications in high Impact Factor (IF > 10) journals
- Six publications developing useful statistical methodologies and
- Six collaborative publications across Rutgers Cancer Institute’s research programs.
High Impact Factor Publications (13)
Jabbour SK, Berman AT, Decker RH, Lin Y, Feigenberg SJ, Gettinger SN, Aggarwal C, Langer CJ, Simone CB, 2nd, Bradley JD, Aisner J, Malhotra J. Phase 1 Trial of Pembrolizumab Administered Concurrently With Chemoradiotherapy for Locally Advanced Non-Small Cell Lung Cancer: A Nonrandomized Controlled Trial. JAMA Oncol. 2020;6(6):848-55. doi: 10.1001/jamaoncol.2019.6731. PubMed PMID: 32077891; PMCID: PMC7042914.
Evens AM, Danilov A, Jagadeesh D, Sperling A, Kim SH, Vaca R, Wei C, Rector D, Sundaram S, Reddy N, Lin Y, Farooq U, D'Angelo C, Bond DA, Berg S, Churnetski MC, Godara A, Khan N, Choi YK, Yazdy M, Rabinovich E, Varma G, Karmali R, Mian A, Savani M, Burkart M, Martin P, Ren A, Chauhan A, Diefenbach C, et al. Burkitt lymphoma in the modern era: real-world outcomes and prognostication across 30 US cancer centers. Blood. 2021;137(3):374-86. doi: 10.1182/blood.2020006926. PubMed PMID: 32663292; PMCID: PMC8765121.
Bandera EV, Qin B, Lin Y, Zeinomar N, Xu B, Chanumolu D, Llanos AAM, Omene CO, Pawlish KS, Ambrosone CB, Demissie K, Hong CC. Association of Body Mass Index, Central Obesity, and Body Composition With Mortality Among Black Breast Cancer Survivors. JAMA Oncol. 2021;7(8):1-10. doi: 10.1001/jamaoncol.2021.1499. PubMed PMID: 34086040; PMCID: PMC8377573.
Yang Y, Karsli-Uzunbas G, Poillet-Perez L, Sawant A, Hu ZS, Zhao Y, Moore D, Hu W, White E. Autophagy promotes mammalian survival by suppressing oxidative stress and p53. Genes Dev. 2020;34(9-10):688-700. doi: 10.1101/gad.335570.119. PubMed PMID: 32193353; PMCID: PMC7197357.
Yu X, Kogan S, Chen Y, Tsang AT, Withers T, Lin H, Gilleran J, Buckley B, Moore D, Bertino J, Chan C, Kimball SD, Loh SN, Carpizo DR. Zinc Metallochaperones Reactivate Mutant p53 Using an ON/OFF Switch Mechanism: A New Paradigm in Cancer Therapeutics. Clin Cancer Res. 2018;24(18):4505-17. doi: 10.1158/1078-0432.Ccr-18-0822. PubMed PMID: 29914895; PMCID: PMC6139040.
Liu J, Zhang C, Wu H, Sun XX, Li Y, Huang S, Yue X, Lu SE, Shen Z, Su X, White E, Haffty BG, Hu W, Feng Z. Parkin ubiquitinates phosphoglycerate dehydrogenase to suppress serine synthesis and tumor progression. J Clin Invest. 2020;130(6):3253-69. doi: 10.1172/jci132876. PubMed PMID: 32478681; PMCID: PMC7260041.
Ferrari AC, Alumkal JJ, Stein MN, Taplin ME, Babb J, Barnett ES, Gomez-Pinillos A, Liu X, Moore D, DiPaola R, Beer TM. Epigenetic Therapy with Panobinostat Combined with Bicalutamide Rechallenge in Castration-Resistant Prostate Cancer. Clin Cancer Res. 2019;25(1):52-63. doi: 10.1158/1078-0432.Ccr-18-1589. PubMed PMID: 30224345.
Son Y, Osornio-Vargas Á R, O'Neill MS, Hystad P, Texcalac-Sangrador JL, Ohman-Strickland P, Meng Q, Schwander S. Land use regression models to assess air pollution exposure in Mexico City using finer spatial and temporal input parameters. Sci Total Environ. 2018;639:40-8. doi: 10.1016/j.scitotenv.2018.05.144. PubMed PMID: 29778680.
Stapleton JL, Hrywna M, Coups EJ, Delnevo C, Heckman CJ, Xu B. Prevalence and Location of Indoor Tanning Among High School Students in New Jersey 5 Years After the Enactment of Youth Access Restrictions. JAMA Dermatol. 2020;156(11):1223-7. doi: 10.1001/jamadermatol.2020.2935. PubMed PMID: 32876658; PMCID: PMC7489374.
Wang SJ, Khullar K, Kim S, Yegya-Raman N, Malhotra J, Groisberg R, Crayton SH, Silk AW, Nosher JL, Gentile MA, Mehnert JM, Jabbour SK. Effect of cyclo-oxygenase inhibitor use during checkpoint blockade immunotherapy in patients with metastatic melanoma and non-small cell lung cancer. J Immunother Cancer. 2020;8(2). doi: 10.1136/jitc-2020-000889. PubMed PMID: 33020239; PMCID: PMC7537331.
Chen H, Thomas C, Munoz FA, Alexandrescu S, Horbinski CM, Olar A, McGuone D, Camelo-Piragua S, Wang L, Pentsova E, Phillips J, Aldape K, Chen W, Iafrate AJ, Chi AS, Zagzag D, Golfinos JG, Placantonakis DG, Rosenblum M, Ohman-Strickland P, Hameed M, Snuderl M. Polysomy is associated with poor outcome in 1p/19q codeleted oligodendroglial tumors. Neuro Oncol. 2019;21(9):1164-74. doi: 10.1093/neuonc/noz098. PubMed PMID: 31140557; PMCID: PMC7571489.
Qin B, Kim K, Goldman N, Rundle AG, Chanumolu D, Zeinomar N, Xu B, Pawlish KS, Ambrosone CB, Demissie K, Hong CC, Lovasi GS, Bandera EV. Multilevel Factors for Adiposity Change in a Population-Based Prospective Study of Black Breast Cancer Survivors. J Clin Oncol. 2022;40(20):2213-23. doi: 10.1200/JCO.21.02973. PubMed PMID: 35333586; PMCID: PMC9273374.
Yegya-Raman N, Wang K, Kim S, Reyhan M, Deek MP, Sayan M, Li D, Patel M, Malhotra J, Aisner J, Marks LB, Jabbour SK. Dosimetric Predictors of Symptomatic Cardiac Events After Conventional-Dose Chemoradiation Therapy for Inoperable NSCLC. J Thorac Oncol. 2018;13(10):1508-18. doi: 10.1016/j.jtho.2018.05.028. PubMed PMID: 29883836.
Methodological Development (6)
Moore DF, Sleat DE, Lobel P. A Method to Estimate the Distribution of Proteins across Multiple Compartments Using Data from Quantitative Proteomics Subcellular Fractionation Experiments. J Proteome Res. 2022;21(6):1371-81. doi: 10.1021/acs.jproteome.1c00781. PubMed PMID: 35522998.
Han Y, Liu H, Cao S, Zhang C, Zang Y. TSNP: A two-stage nonparametric phase I/II clinical trial design for immunotherapy. Pharmaceutical Statistics. 2021;20(2):282-96. doi: https://doi.org/10.1002/pst.2075.
Hu L, Lin JY, Sigel K, Kale M. Estimating heterogeneous survival treatment effects of lung cancer screening approaches: A causal machine learning analysis. Ann Epidemiol. 2021;62:36-42. doi: 10.1016/j.annepidem.2021.06.008. PubMed PMID: 34157399; PMCID: PMC8463451.
Lin Y, Shih WJ, Lu SE. Two-stage enrichment clinical trial design with adjustment for misclassification in predictive biomarkers. Stat Med. 2019;38(29):5445-69. doi: 10.1002/sim.8370. PubMed PMID: 31621944; PMCID: PMC6842057.
Liu H, Lin X, Huang X. An oncology clinical trial design with randomization adaptive to both short- and long-term responses. Stat Methods Med Res. 2019;28(7):2015-31. doi: 10.1177/0962280217744816. PubMed PMID: 29233085.
Liu H, Qin J. Semiparametric probit models with univariate and bivariate current-status data. Biometrics. 2018;74(1):68-76. doi: https://doi.org/10.1111/biom.12709.
Examples of Other Collaborative Publications (6)
Pearson J, Ganz O, Ohman-Strickland P, Wackowski OA . Shifts in preference for Natural American Spirit and associated belief that one's own cigarette brand might be less harmful than other brands: results from Waves 1-4 of the Population Assessment of Tobacco and Health (PATH) Study (2013-2018). Tob Control. 2021 DEC 24; . DOI: 10.1136/tobaccocontrol-2021-056985. 2021 Dec 24. PubMed PMID: 34952863.
Qin B, Xu B, Ji N, Yao S, Pawlish K, Llanos AAM, Lin Y, Demissie K, Ambrosone CB, Hong CC, Bandera EV. Intake of vitamin D and calcium, sun exposure, and risk of breast cancer subtypes among black women. Am J Clin Nutr. 2020 FEB 01; 111(2):396-405. DOI: 10.1093/ajcn/nqz302. PubMed PMID: 31826233; PMCID: PMC6997081.
Na B, Yu X, Withers T, Gilleran J, Yao M, Foo TK, Chen C, Moore D, Lin Y, Kimball SD, Xia B, Ganesan S, Carpizo DR. Therapeutic targeting of BRCA1 and TP53 mutant breast cancer through mutant p53 reactivation. NPJ Breast Cancer. 2019 JAN 01; 5:14. DOI: 10.1038/s41523-019-0110-1. 2019 Apr 15. PubMed PMID: 30993195; PMCID: PMC6465291.
Jang TL , Patel N, Faiena I, Radadia KD, Moore DF , Elsamra SE, Singer EA, Stein MN, Eastham JA, Scardino PT, Lin Y , Kim IY, Lu-Yao GL. Comparative effectiveness of radical prostatectomy with adjuvant radiotherapy versus radiotherapy plus androgen deprivation therapy for men with advanced prostate cancer. Cancer. 2018 OCT 15; 124(20):4010-4022. DOI: 10.1002/cncr.31726. 2018 Sep 25. PubMed PMID: 30252932; PMCID: PMC6234085.
Llanos AAM, Lin Y , Chen W, Yao S, Norin J, Chekmareva MA, Omene C, Cong L, Omilian AR, Khoury T, Hong CC, Ganesan S, Foran DJ , Higgins M, Ambrosone CB, Bandera EV , Demissie K. Immunohistochemical analysis of adipokine and adipokine receptor expression in the breast tumor microenvironment: associations of lower leptin receptor expression with estrogen receptor-negative status and triple-negative subtype. Breast Cancer Res. 2020 FEB 11; 22(1):18. DOI: 10.1186/s13058-020-1256-3. 2020 Feb 11. PubMed PMID: 32046756; PMCID: PMC7014630.
Singh VK, Rastogi A, Hu X, Wang Y, De S. Mutational signature SBS8 predominantly arises due to late replication errors in cancer. Commun Biol. 2020 AUG 03; 3(1):421. DOI: 10.1038/s42003-020-01119-5. 2020 Aug 3. PubMed PMID: 32747711; PMCID: PMC7400754.